Like competitors Bennett X-Rayand Lorad, Fischer will display its work in full-breast digitalmammography. The Denver-based Fischer has marketed its Mammovisiondigital spot mammography device since 1992 (SCAN 10/7/92). Fischer will have a full-breast
Like competitors Bennett X-Rayand Lorad, Fischer will display its work in full-breast digitalmammography. The Denver-based Fischer has marketed its Mammovisiondigital spot mammography device since 1992 (SCAN 10/7/92).
Fischer will have a full-breast digital prototype on the RSNAmeeting floor as a work-in-progress and will show images fromthe system, according to Jean-Pierre Georges, vice president ofmarketing. Fischer also plans to put more emphasis on its Sophiemammography unit, which it outsourced from Planmed of Finland(SCAN 10/6/93). In addition, Fischer has made ergonomic and imagequality improvements to its mid-tier Athena mammography unit.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.